Products and Services
Products and Services
Active Pharmaceutical Ingredients
Product Name
CAS Number
Specification
DMF
CEP
Status
CN
PV
Cabozantinib
849217-68-1
In-house
Q4 2025
Dabrafenib mesylate
1195768-06-9
In-house
Q4 2025
Imatinib Mesylate
220127-57-1
EP, In-house
√
CEP2023- 303-Rev 00
Lenvatinib Mesylate
857890-39-2
In-house
√
Olaparib
763113-22-0
In-house
√
Osimertinib mesylate
1421373-66-1
In-house
Q4 2025
Palbociclib
571190-30-2
In-house
√
Ruxolitinib (Phosphate)
941678-49-5&1092939-17-7
In-house
√
Trametinib dimethyl sulfoxide
1187431-43-1
In-house
Q4 2025
Tofacitinib Citrate
540737-29-9
In-house
√
Bulevirtide
2012558-47-1
Q1 2028
Q3 2027
Enlicitide chloride
2407527-16-4
Q1 2028
Q3 2027
Etelcalcetide Hydrochloride
1334237-71-6
Q4 2026
Completed
Icotrokinra
2763602-16-8
Q2 2027
Q4 2026
Inclisiran sodium
1639324-58-5
Q2 2028
Q4 2027
Lanreotide acetate
127984-74-1
Q1 2027
Q2 2026
Setmelanotide
1504602-49-6
Q2 2027
Q4 2026
Vosoritide
1480724-61-5
Q1 2027
Q4 2026
Acalabrutinib
1420477-60-6
Q1 2027
Q3 2026
Avapritinib
1703793-34-3
Q2 2027
Q4 2026
Email:
Company Address:
No.5, Donghai 4th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Taizhou,Zhejiang,China
